A Monocenter Pilot Study
This prospective pilot study evaluates the use of SPECT/CT bone scan imaging to identify appropriate surgical targets for spinal fusion in patients with degenerative disorders. The primary goal is to assess patient inclusion feasibility for a potential future multi-center trial.
David Werner, MD, PhD
Department of Neurosurgery
Stavanger University Hospital
Email: david.werner@sus.no
This is a prospective, open-label, monocentre feasibility trial conducted at Stavanger University Hospital in collaboration between the Neurosurgical and Orthopaedic departments.
Monocentre trial at Stavanger University Hospital (Neurosurgery & Orthopaedics)
Adults aged 18-75 with chronic low back pain or requiring fusion for neural decompression
SPECT/CT bone scan to identify high osteoblastic activity zones
3 and 12 months post-operative assessments
Chronic low back pain is the major cause of disability worldwide. While spinal fusion surgery for back pain remains controversial, recent evidence suggests that SPECT/CT imaging can identify pain generators in the degenerative spine by measuring osteoblastic activity. High intensity zones on SPECT/CT may indicate areas of instability causing pain, potentially predicting which patients will benefit from fusion surgery.
SPECT/CT combines functional imaging (measuring bone metabolism) with high-resolution anatomical CT imaging, allowing precise localization of potential pain generators in spinal degenerative disease.
Primary Objective: Assess the potential number of patients that could be included at our unit in a potential multi-center trial (feasibility assessment).
Secondary Objectives: Investigate changes in established outcome measures after lumbar fusion surgery in surgical targets identified by SPECT/CT.
Inclusion: Adults 18-75 with chronic low back pain (>6 months), worse than leg pain, unresponsive to ≥3 months of structured physical therapy.
Treatment: Offered fusion surgery if SPECT/CT shows positive findings (high intensity zones).
Inclusion: Adults 18-75 with leg pain ≥ back pain, requiring fusion for neural decompression (spondylolysis, spondylolisthesis, facet joint pathology, foraminal stenosis).
Treatment: Undergo fusion surgery regardless of SPECT/CT findings, allowing comparison of outcomes.
Spinal fusion will be performed using an interbody implant (cage filled with bone graft) with optional posterior instrumentation (pedicle screws and rods). The approach (anterior, lateral, or posterior) will be determined by the surgical team based on individual patient anatomy and pathology.
SPECT/CT Radiation: Average exposure is approximately 4.5-5 millisieverts (mSv) per examination.
Surgical Risks: Inherent risks include implant malposition, neurological deficits, infection, pseudoarthrosis, and chronic pain, which will be carefully monitored throughout the study.
Patient-reported outcomes will be collected using the Norwegian Registry for Spine Surgery (NORspine) questionnaires. Data will be sent by mail with follow-up contact by the research nurse for non-responders. Functional assessments will be conducted by the research team.
Pre-operative assessment including SPECT/CT imaging and outcome questionnaires
First post-operative assessment of outcomes and functional status
Final assessment with comprehensive outcome measures
Expected recruitment per year will be estimated with 95% confidence intervals based on the Poisson distribution. Proportions will be reported with 95% Wilson CIs. Mean changes and standard deviations will be reported with 95% CIs based on normal approximation.
Study protocol finalized and approved by research team
Completed: 2024Ethics approval obtained from Research Ethics Committee (REC)
Completed: 2024Enrolling patients from neurosurgical and orthopaedic departments
In Progress: 2024-2025Pre-operative imaging and surgical interventions for enrolled patients
Ongoing during recruitment phase3-month and 12-month outcome assessments for all participants
Planned: Throughout study periodStatistical analysis of feasibility metrics and clinical outcomes
Planned: Upon completion of follow-upsPublication in open access journal and presentation at scientific meetings
Planned: Following data analysisThis collaborative study brings together expertise from neurosurgery, orthopaedics, radiology, rehabilitation medicine, and biostatistics at Stavanger University Hospital and the University of Stavanger.
Overlege, PhD
Principal Investigator
Department of Neurosurgery
Stavanger University Hospital
Overlege, PhD
Section Leader, Research Section
Associate Professor in Orthopedics
Department of Orthopaedic Surgery
Stavanger University Hospital & University of Stavanger
Overlege, PhD
Department of Neurosurgery
Stavanger University Hospital
Seksjonsoverlege
Department of Orthopaedic Surgery
Stavanger University Hospital
Seksjonsoverlege NM/PET
Department of Radiology
Nuclear Medicine/PET Section
Stavanger University Hospital
Professor of Statistics
Department of Mathematics and Physics
Faculty of Science and Technology
University of Stavanger
Avd. sjef/avd. overlege
Department of Physical Medicine and Rehabilitation
Stavanger University Hospital
Research Nurse
Department of Neurosurgery
Stavanger University Hospital
Data Monitoring Committee: Two external clinicians and one biostatistician
Lead Investigator/Sponsor: David Werner, MD, PhD
Our study design is informed by recent published evidence demonstrating the efficacy of SPECT/CT-guided spinal fusion surgery.
Study: "Spinal fusion for single-level SPECT/CT positive lumbar degenerative disc disease: the SPINUS I study" published in Acta Neurochirurgica (2023) 165:2633-2640
Authors: Radek Kaiser, Michal Varga, Otto Lang, Petr Waldauf, Petr Vaněk, Karel Saur, Vladimír Beneš, David Netuka
Key Finding: The study demonstrated successful outcomes in patients with multi-level degeneration where SPECT/CT imaging identified high uptake zones corresponding to pain generators. Figure 1 from the study shows:
This validates the concept that SPECT/CT can identify specific levels requiring surgical intervention even in multi-level degenerative disease.
Visual Analog Scale (VAS) for Pain:
Oswestry Disability Index (ODI):
Key Finding: These published results from SPECT/CT-guided single-level lumbar fusion demonstrate that patients with positive SPECT/CT findings achieve significant and sustained improvements in both pain and functional disability. This evidence supports the rationale for our pilot feasibility study.
Overview of the study design
Radionuclides and Tissues: SPECT imaging uses Technetium-99m (Tc-99m) as the radiotracer to identify areas of increased osteoblastic activity in the spine. Different radiopharmaceuticals can target specific tissues and metabolic processes.
Generator Methodology: The procedure uses a generator methodology where no Molybdenum-99 (Mo-99) is injected, only Technetium-99m (Tc-99m), ensuring patient safety with targeted imaging.
Apparatus: Modern SPECT/CT scanners combine functional imaging (SPECT) with high-resolution anatomical imaging (CT) to produce detailed tomographic images showing both metabolic activity and anatomical structure.
Inclusion Criteria:
Pathway:
SPECT/CT → If Positive → TLIF/ALIF/LLIF fusion surgery
Inclusion Criteria:
Pathway:
SPECT/CT → Positive/Negative → TLIF/ALIF/LLIF fusion surgery
Recruitment rate + Loss to follow-up
TLIF - Transforaminal Lumbar Interbody Fusion
ALIF - Anterior Lumbar Interbody Fusion
LLIF - Lateral Lumbar Interbody Fusion
The choice of surgical approach will be individualized based on patient anatomy, pathology, and surgeon preference.